AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUL 302 min read$VTIX

Slayter Cameron sold $7K of VTIX

Slayter Cameron (Chief Product Officer) sold 3,985 shares of Virtuix Holdings Inc. (VTIX) at $1.67 on 2026-07-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Slayter Cameron
Published Jul 30, 2026, 1:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 30, 2026, 1:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$VTIX
Neutral
high confidence
Mentioned
$VTIX
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTIXNeutralLow
01

Why it matters

The disclosed open-market sale may be read as mild negative sentiment, but the 10b5-1 structure reduces the informational content about near-term fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure alone is unlikely to drive a material repricing.

03

What to watch

The article does not disclose any offsetting insider buys, changes in guidance, or operational developments, limiting interpretability.

Relevance 2/10Novelty 3/10Timing: immediately after the 2026-07-29 Form 4 filing

Background

This is an SEC Form 4 insider transaction for Virtuix Holdings, reported by Chief Product Officer Slayter Cameron.

Company-level read

Ticker impact

$VTIXNeutralHigh confidence
Context

Virtuix Holdings insider Slayter Cameron sold 3,985 shares at $1.6700 on 2026-07-29 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a Form 4 open-market sale by an officer, explicitly under a pre-arranged 10b5-1 plan, with no accompanying fundamental change disclosed.

Market effects

Sector

Minimal, as this is company-specific insider transaction with no sector-wide catalyst.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • issuer
    Virtuix Holdings Inc.

    Subject of the Form 4 insider transaction (VTIX).

  • insider
    Slayter Cameron

    Chief Product Officer who sold 3,985 shares under a 10b5-1 plan.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

VTIX insider trading history →

Related articles

SEP 9
$VTIXMed

Quarterly revenue beat analyst expectations by more than 50% at Virtuix

Virtuix (VTIX) reported quarterly revenue exceeding analyst expectations by over 50%, driven by strong consumer demand for its Omni One platform. The company will present at the H.C. Wainwright conference, highlighting expansions into defense, robotics, healthcare, and enterprise markets, including partnerships with Tesla and the U.S. Marine Corps. VTIX stock declined 9.52% on the news.

stocktitan.net2 min
AUG 26
$VTIXMed

Research firm sees 644% potential upside for Virtuix; orders rose 72% after Meta partnership

Emerging Growth Research reaffirmed its Buy-Emerging rating and $9.00 price target for Virtuix (VTIX), implying 644% upside. Q1 2027 revenue was $0.8M, down 26% YoY but above estimates, driven by a 72% rise in new orders post-Meta partnership. Gross margin expanded to 30%, and EPS improved sequentially to $(0.22). The firm projects 19% and 275% revenue growth for fiscal 2027 and 2028, respectively, but notes execution and financing risks.

stocktitan.net2 min
AUG 20
$VTIXMed

Virtuix Holdings Inc. (VTIX): Results of Operations and Financial Condition

Virtuix Holdings Inc. (VTIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Virtuix Reports First Quarter Fiscal Year 2027 Results as Omni One Orders Increase 150% Following Meta Launch Orders Increased 72% Year-over-Year and Approximately 150% Since the Launch of Omni One for Quest as Meta Launch Drives Accelerating Consumer Demand Gross Pr

SEC EDGAR 8-K2 min
AUG 19
$VTIXHigh

Virtuix Q1 sales $767K, EPS ($0.22) beat estimates

Virtuix (VTIX) reported Q1 FY2027 net sales of $767K, beating estimates, with a net loss per share of ($0.22). Gross profit rose 29% to $227K, driven by higher selling prices. Operating expenses increased 86% to $4.1M. The company secured its first Omni One Enterprise sale to Tesla. Cash reserves stood at $7.4M. The earnings release and conference call were rescheduled to August 19-20, 2026, due to a new audit firm's review.

scanx.trade3 min
AUG 19
$VTIXMed

Virtuix Reports 72% Year-over-Year Order Growth, Margin Expansion, and New Defense, Enterprise, and Healthcare Wins in Fiscal Q1 2027

Virtuix reported a 72% year-over-year increase in orders and a 29% rise in gross profit for Q1 2027. Gross margin expanded to 30% from 17%. The company secured new defense, enterprise, and healthcare contracts, including deals with Tesla, NASA, and the U.S. Marine Corps. Net sales were $0.8 million, down 26% year-over-year, but orders surged.

quiverquant.com2 min